mRNA Cancer Vaccine Succeeds in Major Clinical Trial

A personalized mRNA cancer vaccine has succeeded in a late-stage clinical trial for melanoma, opening the door to a new era of cancer treatment.

This breakthrough could transform how doctors prevent and treat multiple types of cancer.